12.6 - 13.68
11.56 - 47.9
Join Discuss about INBX with like-minded investors
Vorrei sapere se qualcuno sta seguendo la vicenza INBX
134 Replies 7 👍 7 🔥
Next Dividend Date
Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. Inhibrx has collaborations with bluebird bio, Bristol-Myers Squibb and Chiesi.
HQ: 11025 N. Torrey Pines Road, Suite 200 La Jolla, 92037 California